Over the past decade, drug-eluting stents (DES) have greatly transformed the field of interventional cardiology. Generally, three components are included in a DES system: a metal stent platform ...

Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.

did not outshine standard treatment with second generation drug-eluting stents (DES) as they were expected to, in a surprise ...

The use of drug-eluting stents (DES) has become widespread as a result of their superior revascularization rates compared with those of bare-metal stents (BMS). 1 DES are increasingly being used ...

The team from Doylestown Health's Vascular Surgery is the first in the greater Philadelphia region to use the Abbott ...

The peripheral vascular stent market is projected to grow from USD 4,267.70 million in 2024 to USD 8,878.00 million by 2034, ...

FAME 3 shows women fare similarly with PCI or CABG, while men benefit more from CABG for three-vessel disease.

MUMBAI: Cardiovascular medical device manufacturer Sahajanand Medical Technologies (SMT) has appointed Bhargav Kotadia as chief executive officer and Jose Calle Gordo as chairman, effective 1 April ...

Request To Download Free Sample of This Strategic Report @ The Vietnam stent grafts market is witnessing significant growth attributed to advancements in medical technology and increasing awareness ...